FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q64116828> ?p ?o ?g. }

• Q64116828 description "article scientifique publié en 2019" @default.
• Q64116828 description "artículu científicu espublizáu en febreru de 2019" @default.
• Q64116828 description "bài báo khoa học" @default.
• Q64116828 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
• Q64116828 description "scientific article published on 22 February 2019" @default.
• Q64116828 description "wetenschappelijk artikel" @default.
• Q64116828 description "наукова стаття, опублікована у квітні 2019" @default.
• Q64116828 name "Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer" @default.
• Q64116828 name "Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer" @default.
• Q64116828 type Item @default.
• Q64116828 label "Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer" @default.
• Q64116828 label "Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer" @default.
• Q64116828 prefLabel "Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer" @default.
• Q64116828 prefLabel "Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer" @default.
• Q64116828 P1433 Q64116828-E051A049-75D1-40AB-AEF8-BFC69F52ED7E @default.
• Q64116828 P1476 Q64116828-646D7285-E9A0-4006-9027-DDEBAE508C93 @default.
• Q64116828 P2093 Q64116828-00F5DD80-F325-4B00-BA22-DE51EAE03BD8 @default.
• Q64116828 P2093 Q64116828-0A487D0C-4EA9-4E63-AD0A-ACA83C50E5F3 @default.
• Q64116828 P2093 Q64116828-158168E1-854C-41E7-B676-6B95BD508AB4 @default.
• Q64116828 P2093 Q64116828-3D293D83-D1F0-46D7-988C-A41F98736DBB @default.
• Q64116828 P2093 Q64116828-3E20852C-D663-4C7D-AD3E-978FCC7911F6 @default.
• Q64116828 P2093 Q64116828-4A5687FB-C6C8-4223-AAA2-C26E3C343DF5 @default.
• Q64116828 P2093 Q64116828-77B8E90A-883B-4C99-867A-F3F413B697EB @default.
• Q64116828 P2093 Q64116828-8A5244FA-1444-4F72-AC51-6BBDA25DAC72 @default.
• Q64116828 P2093 Q64116828-8E881352-0248-40AC-808F-C7DED06D5A30 @default.
• Q64116828 P2093 Q64116828-94977BF1-2A11-4B08-924C-6A714B16BED2 @default.
• Q64116828 P2093 Q64116828-AECCFE01-BCEA-4D2E-9AA0-725363C846B9 @default.
• Q64116828 P2093 Q64116828-B9030FD0-C66F-4052-957D-FB1D4CEF031A @default.
• Q64116828 P2093 Q64116828-E7B86DC9-653F-4CA0-B7D3-5A68E7E7765D @default.
• Q64116828 P2860 Q64116828-0653BDFC-E11E-4AA5-8396-D27C18AC99A6 @default.
• Q64116828 P2860 Q64116828-1A10FF77-5F64-428A-8BAA-3A9A533F2630 @default.
• Q64116828 P2860 Q64116828-2B4F271C-E25A-49C2-858D-E8152088BD49 @default.
• Q64116828 P2860 Q64116828-2B916FEC-D1DB-458A-A71C-B7F94F5A8039 @default.
• Q64116828 P2860 Q64116828-316596F1-402C-4763-9776-1AD1E9D2C929 @default.
• Q64116828 P2860 Q64116828-37A07F5D-D918-4F60-8BDB-9717A452FDAA @default.
• Q64116828 P2860 Q64116828-3A7D1F81-B900-45EB-A593-32F7581EDD87 @default.
• Q64116828 P2860 Q64116828-40212DE8-CDD4-4440-AE1D-A0F87EC4307E @default.
• Q64116828 P2860 Q64116828-4D92CACF-BEA0-4841-9808-4227AA02A854 @default.
• Q64116828 P2860 Q64116828-71E16BF5-979F-4E92-A61B-38F83880F186 @default.
• Q64116828 P2860 Q64116828-7B533A46-4BD9-4679-89B3-78730628DA29 @default.
• Q64116828 P2860 Q64116828-7C6135BC-16EF-415F-B88F-AC66603E01FC @default.
• Q64116828 P2860 Q64116828-83A9159F-C835-4C26-AACA-5AE045F766BF @default.
• Q64116828 P2860 Q64116828-92E675DC-B4F8-44D8-BE92-50A7BDD97E3C @default.
• Q64116828 P2860 Q64116828-AAAEC92B-F466-4686-A4B9-6E6A2C3D3737 @default.
• Q64116828 P2860 Q64116828-B5F9FE79-8826-46A9-B1A2-330B366B9858 @default.
• Q64116828 P2860 Q64116828-BCDCA7D9-1C8C-4F51-9C38-F5F9AD04010F @default.
• Q64116828 P2860 Q64116828-BF6B9AA0-7878-492D-8B62-355F168F4B09 @default.
• Q64116828 P2860 Q64116828-D009BEB6-6198-41C6-9FFB-D18B27242A74 @default.
• Q64116828 P2860 Q64116828-D30DC495-83F7-4C11-9D53-0CDECEA68E81 @default.
• Q64116828 P2860 Q64116828-DE81BDAD-092E-4270-A591-790DD47F7AF8 @default.
• Q64116828 P2860 Q64116828-E4871F09-0C50-4E27-8C86-91232A23800D @default.
• Q64116828 P2860 Q64116828-E4917307-9529-401C-B02F-A1CB5E71AA72 @default.
• Q64116828 P2860 Q64116828-EED917D7-B61F-4BEC-9592-67C55CB7F114 @default.
• Q64116828 P2860 Q64116828-F866A8ED-10FB-46D6-B8C0-5EEDAF581453 @default.
• Q64116828 P304 Q64116828-D57C42A1-0722-4D42-9B83-3FD09EF6D810 @default.
• Q64116828 P31 Q64116828-F97BA9E6-ED05-4DC0-98F7-342F575389A6 @default.
• Q64116828 P356 Q64116828-7DE49B80-2C4B-413E-8604-B64B3BBADC55 @default.
• Q64116828 P407 Q64116828-154808CB-1AC3-4F84-BB5B-10A57DDBABD1 @default.
• Q64116828 P433 Q64116828-081B66F0-FF32-4373-9D21-D47F208AF2FF @default.
• Q64116828 P478 Q64116828-89366B33-2AD0-4194-A457-D18DEA6F7983 @default.
• Q64116828 P50 Q64116828-47873A45-9289-4A5E-B20F-FA5911B4114C @default.
• Q64116828 P50 Q64116828-AB2E7C66-9087-455C-95B1-5D0C4E08B620 @default.
• Q64116828 P50 Q64116828-FC1F5066-AE8F-4136-BC11-C6C7C350936D @default.
• Q64116828 P577 Q64116828-0CAFF5C1-A427-445D-BDAC-553837BB09F1 @default.
• Q64116828 P698 Q64116828-6C1264AE-56E2-4F31-8F6C-086276D04223 @default.
• Q64116828 P921 Q64116828-687EA696-E130-4F01-A8D4-FCA9F85A7A1C @default.
• Q64116828 P921 Q64116828-F0087E4D-B338-4A6C-9788-AE2ACAF04672 @default.
• Q64116828 P932 Q64116828-9DA2D20B-BD37-4CFC-AF09-9B4AA3EFE488 @default.
• Q64116828 P356 1759-7714.12986 @default.
• Q64116828 P698 30793872 @default.
• Q64116828 P1433 Q26842004 @default.
• Q64116828 P1476 "Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer" @default.
• Q64116828 P2093 "Chunxia Su" @default.
• Q64116828 P2093 "Fei Zhou" @default.
• Q64116828 P2093 "Fengying Wu" @default.
• Q64116828 P2093 "Guanghui Gao" @default.
• Q64116828 P2093 "Qian Liu" @default.
• Q64116828 P2093 "Qinrui Tian" @default.
• Q64116828 P2093 "Shuo Yang" @default.
• Q64116828 P2093 "Tao Jiang" @default.
• Q64116828 P2093 "Xiaoxia Chen" @default.
• Q64116828 P2093 "Xuefei Li" @default.
• Q64116828 P2093 "Yan Wang" @default.
• Q64116828 P2093 "Yingying Pan" @default.
• Q64116828 P2093 "Yiwei Liu" @default.
• Q64116828 P2860 Q27851712 @default.
• Q64116828 P2860 Q27852787 @default.
• Q64116828 P2860 Q27860881 @default.
• Q64116828 P2860 Q28131668 @default.
• Q64116828 P2860 Q28303718 @default.
• Q64116828 P2860 Q29614403 @default.
• Q64116828 P2860 Q29620648 @default.
• Q64116828 P2860 Q33614314 @default.
• Q64116828 P2860 Q34415427 @default.
• Q64116828 P2860 Q37182213 @default.
• Q64116828 P2860 Q38138826 @default.
• Q64116828 P2860 Q38815763 @default.
• Q64116828 P2860 Q39302684 @default.
• Q64116828 P2860 Q41700218 @default.
• Q64116828 P2860 Q47107157 @default.

• next